PPT-Adverse Drug Reaction

Objectives Explain Pharmacovigilance amp various types of adverse drug reactions List some common adverse effects amp toxicities with examples Discuss drug dependence amp its public health importance . ACTG Network Meeting. June 20, 2011. Ling Chin, MD, MPH. Safety Pharmacovigilance Team Leader, DAIDS. Deborah McMahon. , MD. University of Pittsburgh. ACTG - PEC. Olu Og. unyankin. , MD. DAIDS RSC . Safety & Pharmacovigilance Specialist. Presentation to HL7 Patient Care WG . Draft Recommendations for Canadian Standards (being discussed). NB: HL7 . meeting discussion notes are included on slide 21. . Post meeting notes from . Russell B. Leftwich, M.D.,  . Teaching Aims. You will learn all about adverse donor reaction and prevention of certain reactions. . You will learn to define, identify/diagnose and handle all the reactions.. Adverse Donor Reactions. JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepidemiology. Pharmacovigilance. JAMASOFT2017. 2. P. armacovigilance. system collects data . throughout the . lifecycle . of each . medicinal. . product. The Elephant in the Room: Meaningful Communication of Near Synonyms as Suspected Adverse Reactions A Perspicacious CIOMS View of a Sometimes Tangled Mass of Adverse Reaction Communication Challenges Session #282 MODULE 3 Adverse events following immunizationOverviewUnder recommended conditions all vaccines used in national immunization programmes are safe and e31ective if used correctly In practice however no 1149Pharmacovigilance149Adverse event149Adverse reaction150Unexpected adverse reaction150Serious adverse reaction 149Side effect149Signal149Causality2Definitions149Organisationsinvolved150WHO -World Introduction. Adverse effect:. Any . undesirable or unintended . effect due to . of drug . administration.. It is broad term and includes all kinds of noxious effect such as trivial, serious or even fatal.. (. AEFI). Adverse Events Following Immunization. . (AEFI). . The goal of immunization is to protect individuals from specific disease; but may lead to adverse events that require careful monitoring.. The . risk for development of a drug eruption is related to the following factors: age, gender, dose, and the nature of the medication itself. . Females . are . 1.3-1.5 . times more likely to develop drug eruptions, except in children under the age of 3 where boys are more likely to be affected. . Yousef Ahmed . Alomi. , . Nouf. Hassan . Alamoudi. , . Sabah . Alanazi. , . Abeer. . Hussin. . Almasoudi. ABSTRACT: . Objective: . . To state the physicians and dentists’ knowledge and responsiveness of the adverse drug reaction (ADR) and reporting system in Saudi Arabia. . bumpy) trip from clinical problems to clinical trials. Bill Burman. Denver Public Health. One view of clinical trials. Clinical trials: cautionary notes. Time for a Phase 3 trial – . a decade. (or more!). . Any noxious change which is . Suspected to be due to a drug. At. doses normally . used in man. May requires treatment or decrease in dose or . Caution in the future use of the same drug. ADVERSE DRUG EVENT (ADE. Investigator Kick-off Meeting. January 30-31, Clearwater, Florida. Jodie Riley, MISM and Robert Silbergleit. Adverse Events. Adverse Events (AEs) are “. . . any . untoward. medical occurrence in a subject that was not previously identified which does not necessarily have a causal relationship to the study drug…” .